Results 121 to 130 of about 2,535,651 (215)

Letter to the Editor: 'Rare but relevant: Genetic liver disease in the general medical setting'. [PDF]

Clin Med (Lond)
McCarron EP.
europepmc   +1 more source

Differential Mortality Risk by Age in Males and Females With Steatotic Liver Disease. [PDF]

MedComm (2020)
Yan T, Chien N, Nguyen VH, Le I, Gudapati ST, Chau A, Zhang X, Barnett S, Linden S, Henry L, Cheung R, Nguyen MH.   +11 more
europepmc   +1 more source

Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies. [PDF]

Front Pharmacol
Liang X, He J, Wu Q, Fu L, Liu Y.
europepmc   +1 more source

The Association Between Dietary Protein Intake and Gallstone Disease: A Case–Control Study

Gastroenterology Research and Practice
Amir Sadeghi, Nastaran Raissi-Dehkordi, Azita Hekmatdoost, Moloud Ghorbani, Reyhaneh Rastegar, Mohammad Reza Zali, Negar Raissi-Dehkordi, Zahra Yari   +7 more
doaj   +1 more source

Conjugated bilirubin in chronic liver disease: an underutilised prognostic biomarker?-a narrative review. [PDF]

Transl Gastroenterol Hepatol
Fawcett E, Aravinthan AD.
europepmc   +1 more source

L-carnitine in metabolic dysfunction-associated steatotic liver disease: mechanisms and therapeutic potential. [PDF]

Front Nutr
Chen C, Zou J, Li L, Liu S, Liu Z, Yao L, Peng P, Liang J, Chen Z, Huang H, Huang J.   +10 more
europepmc   +1 more source

Surgery for metabolic liver disease [PDF]

, 1986
Starzl, TE
core  

Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease. [PDF]

Front Pharmacol
Li X, Zhang J, Wei B, Tong H.
europepmc   +1 more source

Palliative care in advanced liver disease. [PDF]

Clin Med (Lond)
Cussen C, Watret A.
europepmc   +1 more source

The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome. [PDF]

Chin Med
Zhang Y, Li H, Yu F, Gao M, Wang Y, Xin S, Yang J, Wang Z, Xiang L, Ru Q, Jiang N.   +10 more
europepmc   +1 more source